[Thrombolysis in acute massive lung embolism]

Abstract

Thrombolytic therapy of pulmonary embolism reduces total pulmonary resistance more rapidly than heparin alone. In massive pulmonary embolism this hemodynamic benefit usually outweighs the moderately increased bleeding risk if contra-indications are strictly observed. Practical dosage regimens for streptokinase and urokinase are proposed.